share_log

啓明醫療-B:董事會召開日期

VENUS MEDTECH-B: DATE OF BOARD MEETING

HKEX ·  Aug 20, 2024 08:30

Summary by Moomoo AI

啓明醫療-B(股份代號:2500)宣布將於2024年8月30日(星期五)召開董事會會議,目的是審議及批准公司及其附屬公司截至2024年6月30日止六個月的中期業績及其發佈。會議同時將考慮是否建議派發中期股息以及處理其他事宜。本次會議由執行董事林浩昇先生主持,並於2024年8月20日發出通知。目前公司的執行董事包括林浩昇先生、馬力喬先生及柳美榮女士,非執行董事為張奧先生及王瑋先生,以及獨立非執行董事胡定旭先生及孫志偉先生。
啓明醫療-B(股份代號:2500)宣布將於2024年8月30日(星期五)召開董事會會議,目的是審議及批准公司及其附屬公司截至2024年6月30日止六個月的中期業績及其發佈。會議同時將考慮是否建議派發中期股息以及處理其他事宜。本次會議由執行董事林浩昇先生主持,並於2024年8月20日發出通知。目前公司的執行董事包括林浩昇先生、馬力喬先生及柳美榮女士,非執行董事為張奧先生及王瑋先生,以及獨立非執行董事胡定旭先生及孫志偉先生。
Qiming Medical - B (Stock Code: 2500) announced that it will hold a board of directors meeting on August 30, 2024 (Friday) to review and approve the company and its subsidiaries' mid-year performance ending on June 30, 2024, as well as its release. The meeting will also consider whether to recommend the distribution of interim dividends and handle other matters. The meeting will be chaired by executive director Mr. Lin Haosheng and was notified on August 20, 2024. The company's current executive directors include Mr. Lin Haosheng, Mr. Ma Lijiao, and Ms. Liu Meirong. The non-executive directors are Mr. Zhang Ao and Mr. Wang Wei, and the independent non-executive directors are Mr. Hu Dingxu and Mr. Sun Zhiwei.
Qiming Medical - B (Stock Code: 2500) announced that it will hold a board of directors meeting on August 30, 2024 (Friday) to review and approve the company and its subsidiaries' mid-year performance ending on June 30, 2024, as well as its release. The meeting will also consider whether to recommend the distribution of interim dividends and handle other matters. The meeting will be chaired by executive director Mr. Lin Haosheng and was notified on August 20, 2024. The company's current executive directors include Mr. Lin Haosheng, Mr. Ma Lijiao, and Ms. Liu Meirong. The non-executive directors are Mr. Zhang Ao and Mr. Wang Wei, and the independent non-executive directors are Mr. Hu Dingxu and Mr. Sun Zhiwei.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
Comment Comment · Views 307

Recommended

Statement

This page is machine-translated. Moomoo tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.